Autogramin-1

CAS No. 2375541-73-2

Autogramin-1( —— )

Catalog No. M26065 CAS No. 2375541-73-2

Autogramin-1 potently inhibits starvation-induced autophagy with IC50 of 0.17 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 334 In Stock
10MG 468 In Stock
25MG 730 In Stock
50MG 918 In Stock
100MG 1293 In Stock
200MG Get Quote In Stock
500MG 2595 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Autogramin-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Autogramin-1 potently inhibits starvation-induced autophagy with IC50 of 0.17 μM.
  • Description
    Autogramin-1 potently inhibits starvation-induced autophagy with IC50 of 0.17 μM. Autogramin-1 also inhibits Rapamycin (mTORC1)-induced autophagy with IC50 of 0.44 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    mTOR
  • Recptor
    P2X3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2375541-73-2
  • Formula Weight
    485.56
  • Molecular Formula
    C23H27N5O5S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 6.94 mg/mL (14.29 mM)
  • SMILES
    CCCn1c(=O)[nH]c2cc(ccc2c1=O)C(=O)Nc1nc2CCN(Cc2s1)C(=O)OC(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Spinaci A, et, al. P2X3 Receptor Ligands: Structural Features and Potential Therapeutic Applications. Front Pharmacol. 2021 Apr 13;12:653561.
molnova catalog
related products
  • mTOR inhibitor 9e

    mTOR inhibitor 9e is a selective mTOR inhibitor with IC50 of 0.68nM and 1359nM for mTOR and PI3Kα, respectively.

  • mTOR inhibitor-8

    mTOR inhibitor-8 is a potent mTOR inhibitor and autophagy inducer with antiviral and antitumor activity. mTOR inhibitor-8 inhibits the growth of A549 cells, which can be used to study non-small cell lung cancer.

  • Seco Rapamycin

    Seco-rapamycin is the first in vivo open-ring metabolite of rapamycin that does not affect mTOR.